Biomolecules,
Journal Year:
2024,
Volume and Issue:
14(12), P. 1507 - 1507
Published: Nov. 26, 2024
Stroke
is
an
often
underrecognized
albeit
significant
complication
in
patients
with
brain
cancer,
arising
from
the
intricate
interplay
between
cancer
biology
and
cerebrovascular
health.
This
review
delves
into
multifactorial
pathophysiological
framework
linking
to
elevated
stroke
risk,
particular
emphasis
on
crucial
role
of
neurotoxic
microenvironment
(NTME).
The
NTME,
characterized
by
oxidative
stress,
neuroinflammation,
blood–brain
barrier
(BBB)
disruption,
creates
a
milieu
that
promotes
sustains
vascular
neuronal
injury.
Key
pathogenic
factors
driving
cancer-related
include
hypercoagulability,
inflammatory
immunological
mechanisms,
other
tumor-associated
processes,
including
direct
tumor
compression,
infection-related
sequelae,
treatment-related
complications.
Recent
advances
genomic
proteomic
profiling
present
promising
opportunities
for
personalized
medicine,
enabling
identification
biomarkers—such
as
oncogenes
suppressor
genes—that
predict
susceptibility
inform
individualized
therapeutic
strategies.
Targeting
NTME
through
antioxidants
alleviate
anti-inflammatory
agents
mitigate
therapies
aimed
at
reinforcing
BBB
could
pave
way
more
effective
prevention
management
integrative
approach
holds
potential
reduce
both
incidence
severity
stroke,
ultimately
improving
clinical
outcomes
quality
life
patients.
Further
research
well-designed
trials
are
essential
validate
these
strategies
integrate
them
routine
practice,
thereby
redefining
risk
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(3), P. 1716 - 1716
Published: Feb. 2, 2022
The
review
aims
to
consolidate
research
findings
on
the
molecular
mechanisms
and
virulence
pathogenicity
characteristics
of
coronavirus
disease
(COVID-19)
causative
agent,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
their
relevance
four
typical
stages
in
development
viral
infection.
These
are
invasion;
primary
blockade
antiviral
innate
immunity;
engagement
virus’s
protection
against
factors
adaptive
acute,
long-term
complications
COVID-19.
invasion
stage
entails
recognition
spike
protein
(S)
SARS-CoV-2
target
cell
receptors,
namely,
main
receptor
(angiotensin-converting
enzyme
2,
ACE2),
its
coreceptors,
potential
alternative
receptors.
presence
a
diverse
repertoire
receptors
allows
infect
various
types
cells,
including
those
not
expressing
ACE2.
During
second
stage,
majority
polyfunctional
structural,
non-structural,
extra
proteins
synthesizes
infected
cells
involved
blockage
immunity.
A
high
degree
redundancy
systemic
action
characterizing
these
pathogenic
overcome
at
initial
invasion.
third
includes
passive
active
virus
from
immunity,
overcoming
barrier
function
focus
inflammation,
generalization
body.
fourth
is
associated
with
deployment
variants
SARS-CoV-2’s
ability
induce
autoimmune
autoinflammatory
pathways
tissue
both
immunosuppressive
hyperergic
inflammation
critical
this
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(9), P. 7910 - 7910
Published: April 26, 2023
Recent
advances
have
greatly
improved
our
understanding
of
the
molecular
mechanisms
behind
atherosclerosis
pathogenesis.
However,
there
is
still
a
need
to
systematize
this
data
from
general
pathology
perspective,
particularly
with
regard
atherogenesis
patterns
in
context
both
canonical
and
non-classical
inflammation
types.
In
review,
we
analyze
various
typical
phenomena
outcomes
cellular
pro-inflammatory
stress
atherosclerosis,
as
well
role
endothelial
dysfunction
local
systemic
manifestations
low-grade
inflammation.
We
also
present
features
immune
development
productive
stable
unstable
plaques,
along
their
similarities
differences
compared
There
are
numerous
factors
that
act
inducers
inflammatory
process
including
vascular
endothelium
aging,
metabolic
dysfunctions,
autoimmune,
some
cases,
infectious
damage
factors.
Life-critical
complications
such
cardiogenic
shock
severe
strokes,
associated
acute
hyperinflammation.
Additionally,
critical
atherosclerotic
ischemia
lower
extremities
induces
paracoagulation
chronic
Conversely,
sepsis,
other
conditions,
diseases
contribute
atherogenesis.
summary,
can
be
characterized
an
independent
form
inflammation,
sharing
but
having
fundamental
variants
(classic
vasculitis).
Molecular Biomedicine,
Journal Year:
2023,
Volume and Issue:
4(1)
Published: Nov. 8, 2023
Abstract
The
Janus
kinase-signal
transducer
and
transcription
activator
pathway
(JAK-STAT)
serves
as
a
cornerstone
in
cellular
signaling,
regulating
physiological
pathological
processes
such
inflammation
stress.
Dysregulation
this
can
lead
to
severe
immunodeficiencies
malignancies,
its
role
extends
neurotransduction
pro-inflammatory
signaling
mechanisms.
Although
JAK
inhibitors
(Jakinibs)
have
successfully
treated
immunological
inflammatory
disorders,
their
application
has
generally
been
limited
diseases
with
similar
pathogenic
features.
Despite
the
modest
expression
of
JAK-STAT
CNS,
it
is
crucial
for
functions
cortex,
hippocampus,
cerebellum,
making
relevant
conditions
like
Parkinson's
disease
other
neuroinflammatory
disorders.
Furthermore,
influence
on
serotonin
receptors
phospholipase
C
implications
stress
mood
This
review
expands
understanding
JAK-STAT,
moving
beyond
traditional
contexts
explore
stress-related
disorders
CNS
function.
Recent
findings,
effectiveness
Jakinibs
chronic
rheumatoid
arthritis,
expand
therapeutic
applicability.
Advances
isoform-specific
inhibitors,
including
filgotinib
upadacitinib,
promise
greater
specificity
fewer
off-target
effects.
Combination
therapies,
involving
monoclonal
antibodies,
aiming
enhance
efficacy
also
give
great
hope.
Overall,
bridges
gap
between
basic
science
clinical
application,
elucidating
complex
human
health
guiding
future
interventions.
Graphical
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(9), P. 4596 - 4596
Published: April 21, 2022
Pro-inflammatory
stress
is
inherent
in
any
cells
that
are
subject
to
damage
or
threat
of
damage.
It
defined
by
a
number
universal
components,
including
oxidative
stress,
cellular
response
DNA
damage,
unfolded
protein
mitochondrial
and
endoplasmic
reticulum
changes
autophagy,
inflammasome
formation,
non-coding
RNA
response,
formation
an
inducible
network
signaling
pathways,
epigenetic
changes.
The
presence
receptor
secretory
phenotype
many
the
cause
tissue
pro-inflammatory
stress.
key
phenomenon
determining
occurrence
classical
inflammatory
focus
microvascular
(exudation,
leukocyte
migration
alteration
zone).
This
same
reaction
at
systemic
level
leads
development
life-critical
inflammation.
From
this
standpoint,
we
can
characterize
common
mechanisms
pathologies
differ
their
clinical
appearance.
division
inflammation
into
alternative
variants
has
deep
evolutionary
roots.
Evolutionary
aspects
also
described
review.
aim
review
provide
theoretical
arguments
for
need
up-to-date
theory
relationship
between
human
pathological
processes
based
on
integrative
role
molecular
Diagnostics,
Journal Year:
2022,
Volume and Issue:
12(3), P. 602 - 602
Published: Feb. 27, 2022
Background:
Coronavirus
2019
(COVID-19),
caused
by
the
severe
acute
respiratory
syndrome
coronavirus
(SARS-CoV-2),
has
created
a
tremendous
economic
and
medical
burden.
The
prevalence
prognostic
value
of
SARS-CoV-2-induced
kidney
impairment
remain
controversial.
current
study
aimed
to
provide
additional
evidence
on
incidence
injury
(AKI)
in
COVID-19
patients
propose
use
urinalysis
as
tool
for
screening
impairment.
Methods:
178
with
confirmed
were
enrolled
this
retrospective
cohort
study.
laboratory
examinations
included
routine
blood
tests,
biochemical
analyses
(liver
function,
renal
lipids,
glucose),
coagulation
index,
lymphocyte
subset
cytokine
analysis,
urine
test,
C-reactive
protein,
erythrocyte
sedimentation,
serum
ferritin.
Results:
No
patient
exhibited
rise
creatinine
or
Cystatin
C
occurrence
AKI,
only
2.8%
recorded
an
elevated
level
urea
nitrogen
among
all
cases.
On
contrary,
54.2%
who
underwent
testing
presented
abnormal
featured
proteinuria,
hematuria,
leucocyturia.
Conclusions:
Kidney
is
prevalent
patients,
clinical
manifestation,
implying
that
test
stronger
indication
prospective
complication
than
biochemistry
test.
Frontiers in Nutrition,
Journal Year:
2023,
Volume and Issue:
10
Published: Aug. 8, 2023
Metabolic
syndrome
(MetS)
is
a
multifaceted
condition
that
increases
the
possibility
of
developing
atherosclerotic
cardiovascular
disease.
MetS
includes
obesity,
hypertension,
dyslipidemia,
hyperglycemia,
endothelial
dysfunction,
and
platelet
hyperactivity.
There
concerning
rise
in
occurrence
frequency
globally.
The
rising
incidence
severity
need
proactive,
multipronged
strategy
for
identifying
treating
those
affected.
For
many
patients,
achieving
recommended
goals
healthy
fat
intake,
blood
pressure
control,
glucose
management
may
require
combination
medicine
therapy,
lifestyles,
nutraceuticals,
others.
However,
it
essential
to
note
lifestyle
modification
should
be
first-line
therapy
MetS.
In
addition,
requires
pharmacological,
nutraceutical,
or
other
interventions.
This
review
aimed
bring
together
etiology,
molecular
mechanisms,
dietary
strategies
combat
dysfunction
individuals
with
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(2), P. 1144 - 1144
Published: Jan. 6, 2023
Currently,
there
is
rationale
for
separating
the
systemic
manifestations
of
classical
inflammation
from
(SI)
itself
as
an
independent
form
general
pathological
process
underlying
pathogenesis
most
severe
acute
and
chronic
diseases.
With
this
aim
in
view,
we
used
integral
scales
SI
(ChSI),
including
following
blood
plasma
parameters:
interleukins
6,
8,
10;
tumor
necrosis
factor
alpha;
C-reactive
protein;
D-dimer;
cortisol;
troponin
I;
myoglobin.
The
presence
multiple
organ
dysfunction
according
to
SOFA
score
was
also
taken
into
account.
effectiveness
tested
groups
intensive
care
patients
during
different
periods
trauma,
sepsis,
septic
shock.
ChSI
scale
applicable
under
autoimmune
diseases,
purulent
infections,
limb
threatening
ischemia,
end-stage
renal
disease
various
genesis.
number
examined
764
total.
allowed
us
verify
specific
phases
identify
pathogenetic
risk
factors
lethal
outcomes,
well
variants
pathologies
course.
These
are
open
adaptable
systems
(in
terms
nomenclature
choice
indicators).
They
primarily
intended
scientific
research.
However,
verification
methodology
presented
paper
may
be
useful
developing
advanced
criteria
assessing
both
typical
links
many
diseases
severity
overall
condition
clinical
practice.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
22(21), P. 11453 - 11453
Published: Oct. 23, 2021
Chronic
kidney
disease
can
progress
to
end-stage
chronic
renal
(ESRD),
which
requires
the
use
of
replacement
therapy
(dialysis
or
transplant)
in
life-threatening
conditions.
In
ESRD,
irreversible
changes
kidneys
are
associated
with
systemic
proinflammatory
nature
and
dysfunctions
internal
organs,
skeletal
muscles,
integumentary
tissues.
The
common
components
ESRD
pathogenesis,
regardless
initial
nosology,
(1)
local
(in
kidneys)
low-grade
inflammation
(ChLGI)
as
a
risk
factor
for
diabetic
its
progression
(2)
classical
type
characteristic
primary
secondary
autoimmune
glomerulonephritis
infectious
recurrent
pyelonephritis,
well
immune
reactions
allograft
rejection,
(3)
(ChSI),
pathogenetically
characterized
by
latent
microcirculatory
disorders
manifestations
paracoagulation.
development
ChSI
is
closely
programmed
hemodialysis
process.
Consideration
pathogenesis
from
standpoint
theory
general
pathological
processes
opens
up
scope
not
only
particular
but
also
universal
approaches
conducting
pathogenetic
therapies
diagnosing
predicting
complications
severe
nephropathies.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(8), P. 4167 - 4167
Published: April 9, 2022
Theophylline
(3-methyxanthine)
is
a
historically
prominent
drug
used
to
treat
respiratory
diseases,
alone
or
in
combination
with
other
drugs.
The
rapid
onset
of
the
COVID-19
pandemic
urged
development
effective
pharmacological
treatments
directly
attack
new
variants
SARS-CoV-2
virus
and
possess
therapeutical
battery
compounds
that
could
improve
current
management
disease
worldwide.
In
this
context,
theophylline,
through
bronchodilatory,
immunomodulatory,
potentially
antiviral
mechanisms,
an
interesting
proposal
as
adjuvant
treatment
patients.
Nevertheless,
it
essential
understand
how
compound
behave
against
such
disease,
not
only
at
pharmacodynamic
but
also
pharmacokinetic
level.
sense,
quickest
approach
discovery
different
computational
methods,
either
from
network
pharmacology
quantitative
systems
approaches.
present
review,
we
explore
possibility
using
theophylline
patients
since
seems
be
relevant
candidate
by
aiming
several
immunological
targets
involved
pathophysiology
disease.
down-regulates
inflammatory
processes
activated
various
herein,
they
are
discussed
reviewing
simulation
studies
their
applications
effects.
Biomolecules,
Journal Year:
2023,
Volume and Issue:
13(5), P. 816 - 816
Published: May 11, 2023
It
is
estimated
that,
at
minimum,
500
million
individuals
suffer
from
cellular
metabolic
dysfunction,
such
as
diabetes
mellitus
(DM),
throughout
the
world.
Even
more
concerning
knowledge
that
disease
intimately
tied
to
neurodegenerative
disorders,
affecting
both
central
and
peripheral
nervous
systems
well
leading
dementia,
seventh
cause
of
death.
New
innovative
therapeutic
strategies
address
metabolism,
apoptosis,
autophagy,
pyroptosis,
mechanistic
target
rapamycin
(mTOR),
AMP
activated
protein
kinase
(AMPK),
growth
factor
signaling
with
erythropoietin
(EPO),
risk
factors
apolipoprotein
E
(APOE-ε4)
gene
coronavirus
2019
(COVID-19)
can
offer
valuable
insights
for
clinical
care
treatment
disorders
impacted
by
disease.
Critical
insight
into
modulation
these
complex
pathways
are
required
since
mTOR
pathways,
AMPK
activation,
improve
memory
retention
in
Alzheimer's
(AD)
DM,
promote
healthy
aging,
facilitate
clearance
β-amyloid
(Aß)
tau
brain,
control
inflammation,
but
also
may
lead
cognitive
loss
long-COVID
syndrome
through
mechanisms
include
oxidative
stress,
mitochondrial
cytokine
release,
APOE-ε4
if
autophagy
other
programmed
cell
death
left
unchecked.